Friedman Brain Institute

Search results

• Mount Sinai Secures $3.26M Grant for Undiagnosed Diseases Center

  Balwani, M. & Gelb, B.

  18/09/24

  1 item of Media coverage

  Press/Media

• Study Findings from Sungkyunkwan University Broaden Understanding of Adenocarcinoma (Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-associated Endocervical Adenocarcinoma Treated By Surgery Alone: ...)

  Lee, W. H.

  18/09/24

  1 item of Media coverage

  Press/Media

• How mental states impact gut health

  Chang, H. & de Araujo, I.

  18/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai secures $3.26m grant for new undiagnosed diseases centre

  Balwani, M. & Gelb, B.

  18/09/24

  1 item of Media coverage

  Press/Media

• How mental states impact gut health

  Chang, H. & de Araujo, I.

  17/09/24

  1 item of Media coverage

  Press/Media

• New $3.26 million grant launches Undiagnosed Diseases Network site in New York

  Balwani, M. & Gelb, B.

  17/09/24

  1 item of Media coverage

  Press/Media

• New Four-Year, $3.26 Million Grant From the National Institute of Neurological Disorders and Stroke Establishes the Mount Sinai Center for Undiagnosed Diseases

  Balwani, M. & Gelb, B.

  17/09/24

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researchers Discuss Research in Science (Neural populations in macaque anterior cingulate cortex encode social image identities)

  Simon, J. & Rich, E.

  17/09/24

  1 item of Media coverage

  Press/Media

• CBD: What Does it Do? Is it Safe?

  Hurd, Y.

  17/09/24

  3 items of Media coverage

  Press/Media

• From Fisk to Taskmaster, the ‘really small’ Aaron Chen is riding high

  Montgomery, G.

  17/09/24

  2 items of Media coverage

  Press/Media

• New four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke establishes the Mount Sinai Center for Undiagnosed Diseases

  Balwani, M. & Gelb, B.

  17/09/24

  1 item of Media coverage

  Press/Media

• Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder

  Iosifescu, D. V.

  16/09/24

  7 items of Media coverage

  Press/Media

• New Borderline Personality Disorder Findings from Icahn School of Medicine at Mount Sinai Discussed (Training In Cognitive Reappraisal Normalizes Whole-brain Indices of Emotion Regulation In Borderline Personality Disorder)

  Goodman, M., Goodman, M. S., Rosell, D., Fan, J., New, A., Hazlett, E., Koenigsberg, H., Perez-Rodriguez, M. D. L. M. & Schulz, K.

  16/09/24

  1 item of Media coverage

  Press/Media

• Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder

  Iosifescu, D. V.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System Is First in Northeast to Use Blood Tests as an Early Detection Tool for Alzheimer’s Disease and Related Dementias in Patients

  Naasan, G. & Elahi, F.

  16/09/24

  2 items of Media coverage

  Press/Media

• Weekly: United Fire Group (UFCS: $20.50) shares post best week in three weeks; +43c [2.1%]

  Green, M.

  16/09/24

  1 item of Media coverage

  Press/Media

• Look to science to prevent suicide

  Galynker, I. I.

  16/09/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System Is First in Northeast to Use Blood Tests as an Early Detection Tool for Alzheimer's Disease and Related Dementias in Patients

  Naasan, G. & Elahi, F.

  16/09/24

  1 item of Media coverage

  Press/Media

• SHAPE and I-ELCAP Announce 1st Conference on Integrating Heart and Lung Screening Using Low-Dose CT to be Held September 19-21, 2024 at the New York Academy of Medicine

  Fuster, V., Henschke, C., Mehran, R. & Yankelevitz , D.

  14/09/24 → 15/09/24

  18 items of Media coverage

  Press/Media

• To prevent suicide, we have to change to a scientific approach

  Galynker, I. I.

  14/09/24

  1 item of Media coverage

  Press/Media

• The RESILIENCE trial: Preventing heart injury caused by anticancer drugs

  Fuster, V.

  13/09/24

  1 item of Media coverage

  Press/Media

• United Fire Group decreases 0.5% in 2024

  Green, M.

  13/09/24

  1 item of Media coverage

  Press/Media

• Anne-Christine Januel named new ESMINT president

  Fifi, J.

  13/09/24

  1 item of Media coverage

  Press/Media

• Biora Therapeutics plummets 51% in 2024, underperforming 82% of the market

  Sands, B. E.

  13/09/24

  1 item of Media coverage

  Press/Media

• 23andMe Holding plummets 64% in 2024, underperforming 88% of the market

  Abul-Husn, N.

  13/09/24

  1 item of Media coverage

  Press/Media